3.21
price down icon4.46%   -0.15
after-market Dopo l'orario di chiusura: 3.22 0.01 +0.31%
loading
Precedente Chiudi:
$3.36
Aprire:
$3.32
Volume 24 ore:
3.38M
Relative Volume:
0.69
Capitalizzazione di mercato:
$342.78M
Reddito:
-
Utile/perdita netta:
$-258.08M
Rapporto P/E:
-1.1673
EPS:
-2.75
Flusso di cassa netto:
$-202.32M
1 W Prestazione:
-3.89%
1M Prestazione:
+15.88%
6M Prestazione:
-70.03%
1 anno Prestazione:
-87.18%
Intervallo 1D:
Value
$3.16
$3.33
Intervallo di 1 settimana:
Value
$3.03
$3.42
Portata 52W:
Value
$2.19
$26.98

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
Nome
Rocket Pharmaceuticals Inc
Name
Telefono
646-440-9100
Name
Indirizzo
350 FIFTH AVENUE, NEW YORK, NY
Name
Dipendente
299
Name
Cinguettio
@rocketpharma
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
RCKT's Discussions on Twitter

Confronta RCKT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RCKT
Rocket Pharmaceuticals Inc
3.21 362.00M 0 -258.08M -202.32M -2.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-30 Downgrade Evercore ISI Outperform → In-line
2025-05-28 Downgrade Goldman Neutral → Sell
2025-05-28 Downgrade JP Morgan Overweight → Neutral
2025-05-28 Downgrade Jefferies Buy → Hold
2025-05-28 Downgrade Leerink Partners Outperform → Market Perform
2025-05-28 Downgrade Morgan Stanley Overweight → Equal-Weight
2025-05-27 Downgrade Needham Buy → Hold
2025-05-27 Downgrade TD Cowen Buy → Hold
2025-03-12 Iniziato BMO Capital Markets Outperform
2024-12-30 Iniziato Wedbush Outperform
2024-12-18 Iniziato Jefferies Buy
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-04-02 Iniziato Goldman Neutral
2023-10-24 Iniziato Cantor Fitzgerald Overweight
2023-02-01 Iniziato Morgan Stanley Overweight
2022-11-08 Iniziato Canaccord Genuity Buy
2022-11-01 Iniziato BTIG Research Buy
2022-07-08 Iniziato Raymond James Outperform
2021-10-20 Ripresa Cowen Outperform
2021-03-02 Iniziato Stifel Buy
2021-02-18 Iniziato Needham Buy
2020-12-16 Iniziato UBS Buy
2020-12-08 Downgrade Oppenheimer Outperform → Perform
2020-07-02 Iniziato JP Morgan Overweight
2020-06-25 Ripresa BofA/Merrill Buy
2020-06-01 Ripresa Oppenheimer Outperform
2019-11-06 Iniziato Chardan Capital Markets Buy
2019-09-26 Iniziato Piper Jaffray Overweight
2019-04-23 Iniziato Robert W. Baird Outperform
2019-03-15 Iniziato BofA/Merrill Buy
2019-02-05 Iniziato Oppenheimer Outperform
2018-09-13 Iniziato Ladenburg Thalmann Buy
2018-07-10 Iniziato William Blair Outperform
Mostra tutto

Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie

pulisher
Jul 24, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Levi & Korsinsky Urges Rocket Pharmaceuticals, Inc. (RCKT) Shareholders to Act Before Lead Plaintiff Deadline August 11, 2025 - Barchart.com

Jul 24, 2025
pulisher
Jul 24, 2025

Investor Alert: Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Trial Safety Concerns - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Rocket Pharmaceuticals Inc. Equity Warrant stockAccelerated investment success - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals to cut 30% of workforce - NJBIZ

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharma falls on delay of certain drug development programs - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals (RCKT) Restructures, Cuts Workforce by 30% - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals cuts headcount, realigns pipeline - Seeking Alpha

Jul 24, 2025
pulisher
Jul 24, 2025

The Fragile Equilibrium: Assessing Rocket Pharmaceuticals Amid Securities Litigation and Governance Concerns - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals (RCKT) Restructures for Strategic Focus a - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Reorganization - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals cuts workforce by 30% to focus on heart therapies - Investing.com Australia

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Corporate Reorganizat - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs - Business Wire

Jul 24, 2025
pulisher
Jul 23, 2025

FDA Clinical Hold on RP-A501 Trial Triggers Rocket - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Rocket Pharmaceuticals Announces Strategic Reorganization Plan - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky - Barchart.com

Jul 23, 2025
pulisher
Jul 23, 2025

Investor Alert: Securities Class Action Filed Against Rocket Pharmaceuticals (RCKT) - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT Class Action Reminder: Robbins LLP Reminds Rocket Pharmaceuticals, Inc. Investors of the Class Action LawsuitContact us for more information - PR Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - PR Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - PR Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

Signaturefd LLC Increases Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Rocket Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastMarket-leading capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - StreetInsider

Jul 22, 2025
pulisher
Jul 22, 2025

Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline - Barchart.com

Jul 22, 2025
pulisher
Jul 22, 2025

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class ActionHagens Berman - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Rocket Pharmaceuticals Inc. Equity Warrant stock priceTremendous growth potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Rocket Pharmaceuticals Inc (RCKT) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT)August 11, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Jul 21, 2025
pulisher
Jul 20, 2025

Is Rocket Pharmaceuticals Inc. a good long term investmentAccelerated capital growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

2025-07-20 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Rocket Pharmaceuticals Inc. stockRapid-fire capital growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Jul 20, 2025
pulisher
Jul 20, 2025

2025-07-20 | RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. InvestorsLead Plaintiff Deadline August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse

Jul 20, 2025
pulisher
Jul 19, 2025

2025-07-19 | RCKT ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Rocket Pharmaceuticals, Inc.August 11, 2025 Deadline | NDAQ:RCKT | Press Release - Stockhouse

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Rocket Pharmaceuticals Inc. stock priceHigh-profit trading signals - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rocket - GlobeNewswire

Jul 19, 2025
pulisher
Jul 18, 2025

Rocket Pharmaceuticals Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Is Rocket Pharmaceuticals Inc. Equity Warrant a good long term investmentUnrivaled growth potential - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

2025-07-18 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky | NDAQ:RCKT | Press Release - Stockhouse

Jul 18, 2025
pulisher
Jul 18, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky Before August 11, 2025 to Join Class Action - TradingView

Jul 18, 2025

Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):